title: Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats.
abstract: Glucosyl hesperidin (G-hesperidin) is a water-soluble derivative of hesperidin. In the present study, the short-term effects of G-hesperidin and hesperetin, a putative metabolite of G-hesperidin, in spontaneously hypertensive rats (SHR) and in normotensive Wistar-Kyoto rats (WKY) were investigated. Single oral administration of G-hesperidin (10 to 50 mg/kg) induced a dose-dependent reduction in systolic blood pressure (SBP) in SHR, but had no effects in WKY. Intraperitoneal injection of hesperetin (50 mg/kg) into SHR also caused a significant reduction in SBP. The depressor effect was significantly inhibited by a nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester. Moreover, hesperetin (10(-5) M) enhanced endothelium-dependent relaxation induced by acetylcholine, but had no effect on endothelium-independent relaxation induced by sodium nitroprusside in isolated aortas from SHR. These data suggest that the hypotensive effect of hesperetin in SHR is associated with nitric oxide-mediated vasodilation. Therefore, this effect may be involved in the mechanisms by which G-hesperidin lowers blood pressure in hypertension.
authors.affiliation: Biological Science Laboratories, Kao Corporation, Tochigi, Japan.
authors.forename: Masaki
authors.initials: M
authors.lastname: Yamamoto
authors.forename: Atsushi
authors.initials: A
authors.lastname: Suzuki
authors.forename: Tadashi
authors.initials: T
authors.lastname: Hase
mesh_terms: D000109:Acetylcholine / Q000008:administration & dosage; D000284:Administration, Oral; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005960:Glucosides / Q000008:administration & dosage / Q000494:pharmacology*; D006569:Hesperidin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007274:Injections, Intraperitoneal; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009599:Nitroprusside / Q000008:administration & dosage; D009924:Organ Culture Techniques; D051381:Rats; D011918:Rats, Inbred SHR; D017208:Rats, Wistar; D013995:Time; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D005960:Glucosides; D014665:Vasodilator Agents; D009599:Nitroprusside; C487382:glucosyl hesperidin; D006569:Hesperidin; D000109:Acetylcholine; C013015:hesperetin; D019331:NG-Nitroarginine Methyl Ester